Send us a text

Dr. Michael Koren shares exciting news about the revival of an oral COVID vaccine study previously halted by government spending cuts. The non-mRNA vaccine trial represents an important alternative approach that apparently received priority status even under strict budget reviews.

• Oral COVID vaccine study in Jacksonville now actively enrolling participants after being temporarily halted by DOGE initiative
• Study offers a non-mRNA alternative that might appeal to those concerned about messenger RNA technology
• Summer months in Florida paradoxically see increases in respiratory infections as people spend more time indoors with air conditioning
• Dr. Koren explains why most vaccines require injection rather than oral delivery
• Discussion of pharmaceutical pricing disparities between US and other countries
• The "innovation premium" Americans pay funds research that benefits the global population
• Finding balance between incentivizing medical breakthroughs and ensuring fair cost distribution remains challenging

For reliable, unbiased medical information, visit MedEvidence.com. To learn more about participating in the oral COVID vaccine study or other clinical trials, visit EncoreDocs.com.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!